TECH
BIO-TECHNE CorpStock analysis · AI equity research
Price
$57.94
Today
+5.35%
Market cap
$9.1B
Run the full AI equity memo on BIO-TECHNE Corp — verdict, the Claremont 7-Gate scorecard, DCF valuation, risks and catalysts, every claim cited.
How Claremont Street analyzes BIO-TECHNE Corp
Claremont Street runs TECH through a 167-point institutional research framework: a 7-gate quality scorecard (moat, balance sheet, reinvestment, management, and more), a discounted-cash-flow valuation with bear/base/bull scenarios, and a structured read of risks and catalysts.
Every figure is pulled from BIO-TECHNE Corp's SEC filings and cited back to the source, ending in a clear Own / Watch / Pass verdict. You keep the decision.
Made with Claremont Street · Patient AI for long-term investors · Research, not investment advice.